Skip to content

Comprehensive molecular profiling of lung adenocarcinoma

Eric Andrew Collisson, Barry S. Taylor, Joshua David Campbell, Angela N. Brooks, Alice H. Berger, Juliann Chmielecki, Gad A. Getz, Peter S. Hammerman, BRYAN HERNANDEZ, Carrie L. Sougnez, Andrew D. Cherniack, Mara W. Rosenberg, Matthew M. Meyerson, Stacey Gabriel, Kristian Cibulskis, Jaegil Kim, Chip Stewart, Eric S. Lander, Michael S. Lawrence, Marcin Imielinski, Robert C. Onofrio, Travis Ian Zack, Elena Helman, Chandra Sekhar Pedamallu, Jill P. Mesirov, Gordon Saksena, Steven E. Schumacher, Scott L. Carter, Levi A. Garraway, Rameen Beroukhim, Juok Cho, Daniel DiCara, David I. Heiman, Pei Lin, William Mallard, Douglas Voet, Hailei Zhang, Lihua Zou, Michael S. Noble, Nils Gehlenborg, Helga Thorvaldsdóttir, Marc-Danie Nazaire, William Lee, Marc Ladanyi, Nikolaus D. Schultz, Ronglai Shen, William David Travis, B. Arman Aksoy, Giovanni Ciriello, Gideon Dresdner, Jianjiong Gao, Benjamin Gross, Venkatraman Seshan, Boris Reva, Rileen Sinha, S. Onur Sumer, Nils Weinhold, Chris Sander, Natasha Rekhtman, Maureen Zakowski, Valerie W. Rusch, David G. Beer, Leslie Cope, Ludmila Danilova, James Gordon Herman, Stephen B. Baylin, Peter Bela Illei, Edward Gabrielson, James Shin, Beverly Lee, Kristen Rodgers, D M Trusty, Malcolm V. Brock, Chad J. Creighton, David Wheeler, Li Ding, Ramaswamy Govindan, Cyriac Kandoth, R J Fulton, Lucinda Fulton, Michael D. McLellan, Richard K. Wilson, Kai Ye, Catrina C. Fronick, Christopher A. Maher, Christopher A. Miller, Michael C. Wendl, Christopher R. Cabanski, Elaine Mardis, Watson Ms, Sandra McDonald, Bryan Fitch Meyers, Raju Kucherlapati, Angela G. Hadjipanayis, Eran Hodis, So Lee, Angeliki Pantazi

Nature · 2014 · 5,803 citationsOpen access

No retraction on record in OpenAlex.Check Crossref now

Cite this paper

Collisson, E. A., Taylor, B. S., Campbell, J. D., Brooks, A. N., Berger, A. H., Chmielecki, J., Getz, G. A., Hammerman, P. S., HERNANDEZ, B., Sougnez, C. L., Cherniack, A. D., Rosenberg, M. W., Meyerson, M. M., Gabriel, S., Cibulskis, K., Kim, J., Stewart, C., Lichtenstein, L., Lander, E. S., … Ren, X. (2014). Comprehensive molecular profiling of lung adenocarcinoma. Nature, 511(7511), 543–550. https://doi.org/10.1038/nature13385

In text: (Collisson et al., 2014)

Ask a question about this research

One question, free, no account. Anchorcite finds the papers, checks each against Crossref and links every sentence of the answer to the passage it comes from.

Abstract

Adenocarcinoma of the lung is the leading cause of cancer death worldwide. Here we report molecular profiling of 230 resected lung adenocarcinomas using messenger RNA, microRNA and DNA sequencing integrated with copy number, methylation and proteomic analyses. High rates of somatic mutation were seen (mean 8.9 mutations per megabase). Eighteen genes were statistically significantly mutated, including RIT1 activating mutations and newly described loss-of-function MGA mutations which are mutually exclusive with focal MYC amplification. EGFR mutations were more frequent in female patients, whereas mutations in RBM10 were more common in males. Aberrations in NF1, MET, ERBB2 and RIT1 occurred in 13% of cases and were enriched in samples otherwise lacking an activated oncogene, suggesting a driver role for these events in certain tumours. DNA and mRNA sequence from the same tumour highlighted splicing alterations driven by somatic genomic changes, including exon 14 skipping in MET mRNA in 4% of cases. MAPK and PI(3)K pathway activity, when measured at the protein level, was explained by known mutations in only a fraction of cases, suggesting additional, unexplained mechanisms of pathway activation. These data establish a foundation for classification and further investigations of lung adenocarcinoma molecular pathogenesis. An integrated transcriptome, genome, methylome and proteome analysis of over 200 lung adenocarcinomas reveals high rates of somatic mutations, 18 statistically significantly mutated genes including RIT1 and MGA, splicing changes, and alterations in MAPK and PI(3)K pathway activity. This report from The Cancer Genome Atlas Research Network presents molecular profiling of 230 resected untreated lung adenocarcinomas. Integrated analyses of transcriptome, genome, methylome and proteome collectively identify high rates of somatic mutation, significantly mutated genes including RIT1 and MGA, splicing alterations driven by somatic genomic changes, and point to as yet unidentified lesions that alter MAPK and PI(3)K pathway activity. These data establish a foundation for classification and further investigations of the leading cause of cancer death worldwide.

  1. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary2021
  2. Hallmarks of Cancer: New Dimensions2022
  3. Comprehensive molecular characterization of human colon and rectal cancer2012
  4. p53 Mutations in Human Cancers1991
  5. Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer2015

Metadata from OpenAlex (CC0). Citations are generated from the published record.